GE HealthCare Unveils Supportive Data for AI-Driven Prediction of Immunotherapy Outcomes
GE HealthCare’s AI can accurately predict patient responses to immunotherapy, as demonstrated in collaborative studies with VUMC and UME. The models, showcasing 70-80% accuracy, may guide more personalized treatment decisions, potentially minimizing side effects…
Continue Reading
